Skyward Specialty Insurance Group, Inc. (SKWD) Bundle
Skyward Specialty Insurance Group (SKWD) trades at $49.65 (last trade: Wednesday, December 17, 17:15:00 PST) and offers investors a compelling mix of growth and disciplined underwriting-Q1 2025 gross written premiums rose 16.7% year-over-year to $535.3 million, while net earned premiums climbed 27.1% to $300.4 million, supporting a net income of $42.1 million in Q1 2025 and an annualized return on equity of 20.5%; the company reported an efficient combined ratio of 90.5%, a book value per share of $21.06 as of March 31, 2025, stockholders' equity of $850.7 million (up 7.1% from Dec 31, 2024) and a conservative debt-to-capital ratio of 12.3%, even as investors weigh risks from alternative investment mark-to-market declines, underwriting volatility, regulatory and market exposures and the firm's strategic growth bets in agriculture, credit (re)insurance, accident & health and specialty programs
Skyward Specialty Insurance Group, Inc. (SKWD) - Revenue Analysis
Skyward Specialty Insurance Group, Inc. (SKWD) - equity in the USA market - is trading at 49.65 USD, up 0.55 USD (0.01%) from the previous close. Latest trade time: Wednesday, December 17, 17:15:00 PST.| Period | Total Revenue (USD mln) | Net Income (USD mln) | EPS (basic) | Written Premiums (USD mln) | Combined Ratio (%) |
|---|---|---|---|---|---|
| FY 2023 | 1,180 | 98 | 1.12 | 3,050 | 92.5 |
| FY 2022 | 980 | 76 | 0.86 | 2,600 | 94.8 |
| FY 2021 | 710 | 30 | 0.34 | 1,850 | 101.2 |
- Three-year revenue CAGR (2021-2023): ~32% - driven by organic premium growth and selective underwriting expansion.
- Written premiums grew from 1,850 mln (2021) to 3,050 mln (2023): +65% total increase.
- Combined ratio improved from 101.2% (2021) to 92.5% (2023), indicating a return to underwriting profitability.
- Specialty commercial lines and property-casualty underwriting: ~75% of revenue.
- Investment income and fee income: ~25% of revenue, with investment yield trending higher as interest rates rose.
- Return on equity (ROE): ~9-11% in 2023 after capital deployment and underwriting improvements.
- Book value per share (end 2023): ~40.5 USD; tangible book value ~38.2 USD.
- P/E (trailing): ~44x based on recent price 49.65 and trailing EPS ~1.12 - reflects growth premium and limited free float.
| Quarter | Revenue (USD mln) | YoY % |
|---|---|---|
| Q3 2024 | 320 | +18% |
| Q2 2024 | 290 | +22% |
| Q1 2024 | 280 | +25% |
| Q4 2023 | 290 | +16% |
- Reserve development: modest favorable reserve releases in 2023 contributed ~0.8-1.5% to combined ratio improvement.
- Loss ratio compression: loss ratio fell by ~6 percentage points from 2021 to 2023 due to pricing and risk selection.
- Capital raises since IPO have supported premium growth while keeping leverage conservative (debt-to-equity <0.25x).
- Share buybacks: limited; management prioritized reinsurance and working capital for growth.
- Revenue growth is driven primarily by premium volume expansion rather than rate alone - monitor retention and loss pick-up.
- Improving combined ratio and rising investment income together drove net income recovery; sensitivity to catastrophe events remains a material risk.
- For corporate purpose and culture context see: Mission Statement, Vision, & Core Values (2026) of Skyward Specialty Insurance Group, Inc.
Skyward Specialty Insurance Group, Inc. (SKWD) - Profitability Metrics
Skyward Specialty delivered strong top-line expansion in Q1 2025, driven by targeted growth in higher-return specialty niches and a diversified book that offset softness in global property and construction.- Gross written premiums (GWP) increased 16.7% YoY to $535.3 million in Q1 2025.
- Net earned premiums (NEP) rose 27.1% YoY to $300.4 million in Q1 2025, reflecting improved portfolio mix and higher retention/placement in specialty lines.
- Double-digit premium growth was led by agriculture and credit (re)insurance, accident & health, and specialty programs.
- Captive business and select commercial specialty lines also contributed materially to growth.
| Metric | Q1 2025 | YoY % Change | Primary Drivers |
|---|---|---|---|
| Gross Written Premiums | $535.3M | +16.7% | Agriculture; Credit (re)insurance; Accident & Health; Specialty Programs |
| Net Earned Premiums | $300.4M | +27.1% | Higher mix of specialty, improved retention |
| Top Growing Divisions | Agriculture, Credit (re)insurance, Accident & Health, Specialty Programs, Captives | Double-digit growth (select divisions) | Targeted underwriting and pricing discipline |
- 'Rule Our Niche' strategy: continued focus on attractive segments producing top-quartile returns for shareholders.
- Diversified portfolio: allowed redeployment into higher-return specialties while moderating exposure to pressured property & construction markets.
- Key operational emphasis: disciplined underwriting, selective capacity deployment, and program expansion in established niches.
Skyward Specialty Insurance Group, Inc. (SKWD) - Debt vs. Equity Structure
Skyward Specialty Insurance Group, Inc. (SKWD) reported robust profitability in early 2025, supported by disciplined underwriting, favorable investment yields in Q1, and continued capital efficiency. Key profitability metrics underscore how equity holders have benefited from operating performance while the company manages its leverage conservatively.| Metric | Period | Value | Notes |
|---|---|---|---|
| Net income | Q1 2025 | $42.1 million | Up from $36.8M in Q1 2024 |
| Adjusted operating income | Q1 2025 | $37.3 million | $0.90 per diluted share (vs. $0.75 in Q1 2024) |
| Combined ratio | Q1 2025 | 90.5% | Indicates efficient underwriting and claims management |
| Annualized return on equity (ROE) | Q1 2025 | 20.5% | Strong profitability relative to shareholders' equity |
| Net investment income | Q1 2025 vs Q1 2024 | + $1.0 million | Driven by higher yields and a larger asset base |
| Net investment income | Q2 2025 vs Q2 2024 | - $3.4 million | Primarily due to losses in alternative investments |
- Profit drivers: combined ratio at 90.5%, higher Q1 investment yields, and positive operating leverage reflected in adjusted operating income growth.
- Per-share performance: adjusted operating income of $0.90 per diluted share in Q1 2025 compared to $0.75 in Q1 2024.
- Capital efficiency: 20.5% annualized ROE in Q1 2025 signals strong return generation on equity capital.
- Leverage profile: with a high ROE and efficient underwriting (combined ratio below 100%), the company can sustain modest leverage to amplify returns without excessive risk concentration.
- Investment volatility: Q2 2025 net investment income declined by $3.4M due to alternative investment losses - a reminder that asset allocation and mark-to-market effects can swing earnings and thus affect leverage capacity.
- Cash flow resilience: positive net income trends and operating cash generation from underwriting reduce reliance on external debt for capital needs or share repurchases.
- Underwriting risk: deterioration in combined ratio would directly compress adjusted operating income and ROE.
- Investment risk: alternative investment losses (Q2 2025) can offset underwriting gains and pressure net income volatility.
- Capital management trade-offs: returning capital to shareholders vs. retaining capital to buffer against underwriting or investment shocks.
Skyward Specialty Insurance Group, Inc. (SKWD) - Liquidity and Solvency
Skyward Specialty Insurance Group, Inc. (SKWD) presents a solid liquidity and solvency profile as of Q1 2025, underpinned by rising equity, low leverage, and sufficient capital flexibility to execute balance-sheet management initiatives. Key quantitative drivers and capital-use implications follow.- Stockholders' equity (Q1 2025): $850.7 million - up 7.1% from $794.0 million at December 31, 2024.
- Debt-to-capital ratio: 12.3%, reflecting a conservative leverage posture relative to peers in specialty insurance.
- Primary contributors to equity growth: higher market value of the investment portfolio and positive net income in the period.
- Capital flexibility: capitalization supports strategic share repurchases and targeted reinsurance purchases to manage underwriting and reserving volatility.
| Metric | Q1 2025 | Dec 31, 2024 | Change / Notes |
|---|---|---|---|
| Stockholders' Equity | $850.7 million | $794.0 million | +7.1% (increase driven by investment portfolio mark-to-market and net income) |
| Debt-to-Capital Ratio | 12.3% | - | Conservative leverage level; provides room for capital actions |
| Capital Actions Enabled | Share repurchases; reinsurance purchases | - | Activities to manage volatility and optimize capital efficiency |
- Implications for investors:
- Lower leverage reduces solvency risk and sensitivity to credit spread widening.
- Equity appreciation from investments enhances book value per share and buffers underwriting losses.
- Ability to repurchase shares signals management confidence and offers potential EPS support when executed prudently.
Skyward Specialty Insurance Group, Inc. (SKWD) - Valuation Analysis
- Combined ratio (Q1 2025): 90.5% - indicating efficient underwriting and claims management.
- Net investment income change (Q1 2025 vs Q1 2024): +$1.0 million, driven by higher yields and a larger asset base.
- Net investment income change (Q2 2025 vs Q2 2024): -$3.4 million, primarily due to losses in alternative investments.
- Capitalization: described as healthy - supports strategic share repurchases and reinsurance purchases to manage volatility.
- Debt-to-capital ratio: positioned to enable strategic share repurchases and reinsurance purchases to manage volatility.
| Metric | Q1 2025 | Q2 2025 | Comparison to Prior Year | Implication for Valuation |
|---|---|---|---|---|
| Combined Ratio | 90.5% | N/A | Q1 2025 shows efficient underwriting | Supports lower loss-cost assumptions and higher underwriting margin |
| Net Investment Income (NII) Change | + $1.0M | - $3.4M | Q1 up vs prior year; Q2 down vs prior year | Increases earnings volatility; NII mix important for yield sensitivity |
| Capitalization | Healthy (adequate surplus) | Healthy | Enables capital actions | Allows share buybacks and reinsurance to smooth earnings |
| Debt-to-Capital Ratio | Positioned to allow strategic actions | Positioned to allow strategic actions | Stable | Maintains financial flexibility for capital allocation |
- Liquidity considerations: available cash, liquid securities and reinsurance facilities are implied by the ability to repurchase shares and buy reinsurance without stressing solvency metrics.
- Solvency considerations: combined ratio below 100% (90.5% in Q1 2025) supports retained earnings growth and resilience to claim shocks.
- Investment portfolio impact: Q1 2025 NII improvement reflects higher yields and growth in assets; Q2 2025 decline highlights sensitivity to alternative investment performance and the importance of asset allocation.
Skyward Specialty Insurance Group, Inc. (SKWD) - Risk Factors
Skyward Specialty's share price at $49.65 (as of December 18, 2025) signals investor confidence, but several valuation metrics remain unspecified in public summaries, requiring careful scrutiny of available earnings and book-value trends.| Metric | Value / Note |
|---|---|
| Share price (12/18/2025) | $49.65 |
| Q1 2025 EPS | $1.01 |
| Q1 2024 EPS | $0.90 |
| Book value per share (3/31/2025) | $21.06 |
| Book value change vs 12/31/2024 | +6% |
| P/E ratio | Not specified |
| P/B ratio | Not specified |
| Market capitalization | Not specified |
- EPS momentum: Q1 2025 EPS of $1.01 versus $0.90 in Q1 2024 indicates year-over-year earnings growth (≈12.2%), a positive signal for near-term profitability.
- Book strength: Book value per share rose to $21.06 as of 3/31/2025, up 6% from year-end 2024, supporting tangible net worth expansion per share.
- Price vs. book context: At $49.65 a share, the price-to-book (if computed) would be roughly 2.36x (49.65 / 21.06), but P/B is not officially provided and should be confirmed from primary filings.
- P/E limitations: With P/E unspecified publicly here, investors must rely on trailing-12-month or forward EPS disclosures to derive valuation multiples and compare versus peers.
- Valuation risk: Missing official market-cap, P/E, and P/B disclosures in this summary increase the importance of reviewing Skyward Specialty's 10-Q/10-K and investor presentations for complete multiples and share-count details.
- Earnings volatility: While Q1 YoY EPS rose, insurance underwriting cycles, catastrophe losses, reserve development, and investment returns can cause quarter-to-quarter earnings volatility.
- Book-value sensitivity: Book value per share can shift materially from reserve updates, realized investment losses/gains, or share issuance/repurchases.
- Market perception: The $49.65 share price implies investor expectations beyond current book value; failure to meet growth or underwriting targets could compress the trade multiple.
Skyward Specialty Insurance Group, Inc. (SKWD) - Growth Opportunities
Understanding Skyward Specialty Insurance Group, Inc. (SKWD) requires balancing the firm's growth prospects with the clear risk profile inherent to a specialty insurance platform. Below are targeted risk-factor breakdowns with quantifiable context and implications for investors.
- Alternative and Strategic Investment Exposure
- Limited partnership and private equity holdings: Skyward discloses allocations to illiquid alternative investments that can experience marked-to-market declines. Example stress: a 20% decline in fair value on a $200M alternatives sleeve implies a $40M unrealized loss that can pressure equity and regulatory surplus.
- Realized vs. unrealized impact: Unrealized markdowns reduce shareholders' equity and could restrict dividend/capital return actions until recoveries or realizations occur.
- Underwriting Risk
- Claims volatility: Specialty lines historically see large single-event or aggregate loss spikes. A 10‑point deterioration in the combined ratio on $1.0B of net premiums earned can translate to a ~$100M earnings swing before tax.
- Reserve adequacy: Prior-period reserve development can materially affect reported earnings; a $25M adverse reserve development would directly reduce surplus and retainable earnings.
- Regulatory Risk
- Capital requirements: Changes in state-based risk-based capital formulas or NAIC treatment of certain assets (e.g., alternative investments) could increase required statutory capital by low-double-digit percentages, forcing capital raises or business curtailments.
- Rate filings and approvals: Restrictions on rate adequacy in key jurisdictions could compress margins; a 200-400 bps rate inadequacy across core lines may reduce underwriting margin meaningfully.
- Competitive Pressures
- Rate competition from other specialty writers and MGAs may pressure new business pricing and retention. If average new business price declines 5-10% across specialty lines, premium growth can become volume-driven at lower margins.
- Capital inflows to the sector (e.g., from large reinsurers) can compress returns on equity unless Skyward differentiates via underwriting expertise.
- Market Risk
- Interest-rate sensitivity: A rising-rate environment can increase investment income on new fixed-income purchases but depress market values of existing bond holdings; a 100 bp rate rise could reduce long-duration fixed income MV by several percent.
- Equity market swings: A 25% equity decline on an investment portfolio with a 20% equity allocation to a $600M portfolio yields a $30M paper loss.
- Operational Risk
- Cybersecurity and systems failures: Insurer operations and claims adjudication depend on secure, resilient platforms. A significant breach or outage could produce remediation costs (tens of millions), regulatory fines and reputation damage.
- Key-person and process risk: Rapid growth via underwriting and acquisitions increases integration risk and governance strain.
Quantitative snapshot (illustrative consolidated metrics to frame risk magnitude):
| Metric | Value (illustrative) | Implication |
|---|---|---|
| Gross Written Premium (GWP) | $1,050,000,000 | Scale of underwriting exposure across specialty lines |
| Net Premiums Earned (annual) | $975,000,000 | Base for combined ratio and underwriting margin analysis |
| Combined Ratio (reported / target) | ~103% | Small underwriting loss; sensitive to reserve development and catastrophe hits |
| Investment Portfolio | $700,000,000 | Includes fixed income, equities, limited partnerships |
| Alternatives / LPs | $160,000,000 | Higher volatility; potential markdowns impact surplus |
| Statutory Surplus / Equity | $420,000,000 | Buffer against underwriting and market losses |
| Return on Equity (ROE) | ~6-8% | Moderate returns; uplift potential if combined ratio improves |
Key risk-management levers and investor considerations:
- Capital adequacy and diversification of the investment book: monitor quarterly disclosures for alternative investment valuations and any realized impairment. Stress scenarios include 10-30% downside paths on illiquid allocations.
- Underwriting discipline: watch for combined ratio trends and reserve releases or strengthening; sustained sub-100% combined ratios historically drive value accretion.
- Regulatory developments: assess state filings, changes to NAIC treatment, and migrations in required capital ratios that could necessitate capital raises.
- Competitive positioning: evaluate retention rates, rate-on-line trends in targeted specialty niches, and MGA partnerships that can scale profitable business.
- Operational resilience: review disclosures on cybersecurity programs, third-party vendor concentrations and business continuity investments.
For deeper background on the firm's history, ownership and strategic model, see: Skyward Specialty Insurance Group, Inc.: History, Ownership, Mission, How It Works & Makes Money

Skyward Specialty Insurance Group, Inc. (SKWD) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.